Rivastigmine Tartrate
- Product NDC
- 51991-796
- 11-digit product format
- 519910796
- Labeler code
- 51991
- Product ID
- 51991-796_e5ca7373-56f1-47e5-a7f9-28359ee55ee4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine Tartrate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Breckenridge Pharmaceutical, Inc
- Application
- ANDA091689
- Marketing category
- ANDA
- Marketing start
- 2012-06-13
- Marketing end
- 2024-12-31
- Substance
- RIVASTIGMINE TARTRATE
- Active strength
- 6 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51991-796-05 | 51991079605 | 500 CAPSULE in 1 BOTTLE (51991-796-05) | 500 capsule | 2012-06-13 | 0000-00-00 | No | No | Current |
| 51991-796-06 | 51991079606 | 60 CAPSULE in 1 BOTTLE (51991-796-06) | 60 capsule | 2012-06-13 | 0000-00-00 | No | No | Current |
| 51991-796-10 | 51991079610 | 1000 CAPSULE in 1 BOTTLE (51991-796-10) | 1000 capsule | 2012-06-13 | 0000-00-00 | No | No | Current |
| 51991-796-11 | 51991079611 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51991-796-11) > 10 CAPSULE in 1 BLISTER PACK | 100 blister pack | 2012-06-13 | 0000-00-00 | No | No | Current |
| 51991-796-33 | 51991079633 | 30 CAPSULE in 1 BOTTLE (51991-796-33) | 30 capsule | 2012-06-13 | 0000-00-00 | No | No | Current |